|Day's Range||50.35 - 50.50|
|52 Week Range||31.47 - 50.50|
|PE Ratio (TTM)||-20.17|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Abbott CEO Miles White said on an earnings call the company will make one more asset sale as part of efforts to gain regulatory approval for the Abbott-Alere deal.
Abbott will report second-quarter numbers on Thursday as it completes the Alere deal. $ABT $ALR
The Triage assets are being divested in order to secure antitrust approvals for Abbott Laboratories' purchase of Alere.